Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Sucampo Pharmaceuticals, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Sucampo Pharmaceuticals, Inc. | v312099_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | v312099_ex31-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | v312099_ex32-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Sucampo Pharmaceuticals, Inc. | v312099_ex10-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | v312099_ex31-2.htm |
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Sucampo Pharmaceuticals, Inc. (the “Company”) certifies to the best of his knowledge that:
| (1) | The Annual Report on Form 10-Q for the period ended March 31, 2012 of the Company (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 10, 2012 | /s/ RYUJI UENO |
| Ryuji Ueno, M.D., Ph.D., Ph.D. | |
| Chief Executive Officer | |
| (Principal Executive Officer) |